These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 2591470)

  • 21. Absorption of theophylline from conventional and sustained-release tablets.
    Mellstrand T; Svedmyr N; Fagerström PO
    Eur J Respir Dis Suppl; 1980; 109():54-60. PubMed ID: 6934088
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A single-dose comparison of three slow-release theophylline oral preparations in healthy Thai volunteers.
    Kanthawatana S; Tontayapiwat A; Tonsuwannont W; Manorot M
    Asian Pac J Allergy Immunol; 1996 Jun; 14(1):13-8. PubMed ID: 8980795
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Performance of a modified starch hydrophilic matrix for the sustained release of theophylline in healthy volunteers.
    Vandenbossche GM; Lefebvre RA; De Wilde GA; Remon JP
    J Pharm Sci; 1992 Mar; 81(3):245-8. PubMed ID: 1640362
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Theophylline disposition after single-dose ingestion of a once-a-day preparation (Dilatrane A. P. 400 mg) with and without breakfast.
    Jonkman JH; Grasmeijer G; Holland A
    Int J Clin Pharmacol Ther Toxicol; 1987 Nov; 25(11):633-7. PubMed ID: 3429067
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative steady-state bioavailability of Theo-24 and Theo-Dur in healthy men.
    Dockhorn RJ; Cefali EA; Straughn AB
    Ann Allergy; 1994 Mar; 72(3):218-22. PubMed ID: 8129214
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Food interactions with sustained-release theophylline preparations. A review.
    Jonkman JH
    Clin Pharmacokinet; 1989 Mar; 16(3):162-79. PubMed ID: 2656048
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Absorption profile and absolute bioavailability of a theophylline sustained-release preparation].
    Pabst G; Weber W; Barkworth MF; Müller M; Rehm KD
    Arzneimittelforschung; 1998 May; 48(5A):574-9. PubMed ID: 9676347
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biopharmaceutic characteristics of a new extended-release theophylline formulation (Uni-Dur).
    Oosterhuis B; Brannan MD; Groen H; Peeters PA; Hempenius J; Radwanski E; Nomeir AA; Affrime MB; Jonkman JH
    Ann Allergy Asthma Immunol; 1995 Aug; 75(2):157-61. PubMed ID: 7648380
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bioavailability and pharmacological effects of two slow-release theophylline preparations: intrasubject tablet-to-tablet variability.
    Rivera-Calimlim L; Calimlim JF; Liang R; Lasagna L; Diamond GL
    J Asthma; 1986; 23(3):113-22. PubMed ID: 3528119
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Theophylline QID, TID, BID and now QD? A report on 24-hour dosing with slow-release theophylline formulations with emphasis on analyses of data used to obtain Food and Drug Administration approval for Theo-24.
    Weinberger MM
    Pharmacotherapy; 1984; 4(4):181-98. PubMed ID: 6483637
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Absorption of Theo-Dur Sprinkle with food: importance of types of meals and medication times.
    Pedersen S
    J Allergy Clin Immunol; 1986 Oct; 78(4 Pt 1):653-60. PubMed ID: 3771955
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics of whole and half Theo-Dur tablets.
    Fagerström PO
    Eur J Respir Dis Suppl; 1980; 109():62-6. PubMed ID: 6934089
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of food on the bioavailability of theophylline from a sustained-released theophylline preparation.
    Lohmann A; Dingler E; Sommer W
    Arzneimittelforschung; 1991 Jul; 41(7):732-4. PubMed ID: 1772462
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Kinetics of absorption of a new once-a-day formulation of theophylline in the presence and absence of food.
    Harrison LI; Mitra AK; Kehe CR; Klinger NM; Wick KA; McCarville SE; Cooper KM; Chang SF; Roddy PJ; Berge SM
    J Pharm Sci; 1993 Jun; 82(6):644-8. PubMed ID: 8331541
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative steady-state bioavailability of sustained-release theophylline preparations: Theo-Dur, Uni-Dur and Xanthium.
    Rojanasthien N; Kovjiriyapan K; Manorot M; Pothirat C
    Asian Pac J Allergy Immunol; 2001 Jun; 19(2):69-78. PubMed ID: 11699723
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A pharmacokinetic study of the recommended dosing schedules of Theo-Dur and Uniphylline.
    Purkiss R; Cope A; Edwards C
    Allergy; 1984 Nov; 39(8):634-8. PubMed ID: 6528959
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of food on bioavailability and pharmacokinetics of theophylline following administration of two sustained release dosage forms: Part I.
    Ohmori N; Inotsume N; Matsukura M; Higashi A; Iwaoku R; Tobino Y; Nakano M; Matsuda I
    Int J Clin Pharmacol Ther Toxicol; 1986 Mar; 24(3):148-52. PubMed ID: 3699941
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sustained release properties of the once daily theophylline capsule BY912 as compared with Theo-24 capsules.
    Jonkman JH; Steinijans VW; Beier W; van der Boon WJ; Crasmeijer G
    Biopharm Drug Dispos; 1989; 10(2):213-24. PubMed ID: 2706320
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Greatly enhanced bioavailability of theophylline on postprandial administration of a sustained release tablet.
    Lagas M; Jonkman JH
    Eur J Clin Pharmacol; 1983; 24(6):761-7. PubMed ID: 6884413
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative bioavailability of two sustained-release theophylline formulations in the dog.
    Mengozzi G; Intorre L; Bertini S; Giorgi M; Soldani G
    Pharmacol Res; 1998 Dec; 38(6):481-5. PubMed ID: 9990658
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.